Daveen Chopra - May 26, 2022 Form 4 Insider Report for Edwards Lifesciences Corp (EW)

Role: CVP, Surgical Structural Heart
Signature: Linda J. Park, Attorney-in-Fact
Stock symbol: EW
Transactions as of: May 26, 2022
Transactions value $: -$98,312
Form type: 4
Date filed: 5/26/2022, 08:06 PM
Previous filing: May 17, 2022
Next filing: Aug 2, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EW	Common Stock	Sale	-$98.3K	-1K	-4.78%	$98.31	19.9K	May 26, 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This transaction was executed in multiple trades at prices ranging from $98.295 to $98.370. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Remarks:

This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.